202 related articles for article (PubMed ID: 37640106)
21. Association of MTHFR C677T variant genotype with serum folate and Vit B12 in Iranian patients with colorectal cancer or adenomatous polyps.
Ghorbani M; Azghandi M; Khayami R; Baharara J; Kerachian MA
BMC Med Genomics; 2021 Oct; 14(1):246. PubMed ID: 34645434
[TBL] [Abstract][Full Text] [Related]
22. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
Chen J; Gammon MD; Chan W; Palomeque C; Wetmur JG; Kabat GC; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Santella RM
Cancer Res; 2005 Feb; 65(4):1606-14. PubMed ID: 15735051
[TBL] [Abstract][Full Text] [Related]
23. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
[TBL] [Abstract][Full Text] [Related]
24. Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer.
Gong J; Hutter CM; Newcomb PA; Ulrich CM; Bien SA; Campbell PT; Baron JA; Berndt SI; Bezieau S; Brenner H; Casey G; Chan AT; Chang-Claude J; Du M; Duggan D; Figueiredo JC; Gallinger S; Giovannucci EL; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jeon J; Jenkins MA; Kocarnik J; Küry S; Le Marchand L; Lin Y; Lindor NM; Nishihara R; Ogino S; Potter JD; Rudolph A; Schoen RE; Schrotz-King P; Seminara D; Slattery ML; Thibodeau SN; Thornquist M; Toth R; Wallace R; White E; Jiao S; Lemire M; Hsu L; Peters U;
PLoS Genet; 2016 Oct; 12(10):e1006296. PubMed ID: 27723779
[TBL] [Abstract][Full Text] [Related]
25. Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer.
Lightfoot TJ; Barrett JH; Bishop T; Northwood EL; Smith G; Wilkie MJ; Steele RJ; Carey FA; Key TJ; Wolf R; Forman D
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2421-30. PubMed ID: 18703816
[TBL] [Abstract][Full Text] [Related]
26. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
Martínez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
[TBL] [Abstract][Full Text] [Related]
27. The Roles of
Wang Y; Du M; Vallis J; Shariati M; Parfrey PS; Mclaughlin JR; Wang PP; Zhu Y
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364857
[TBL] [Abstract][Full Text] [Related]
28. Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.
Han SS; Sue LY; Berndt SI; Selhub J; Burdette LA; Rosenberg PS; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):417-27. PubMed ID: 22253295
[TBL] [Abstract][Full Text] [Related]
29. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence.
Martínez ME; Giovannucci E; Jiang R; Henning SM; Jacobs ET; Thompson P; Smith-Warner SA; Alberts DS
Int J Cancer; 2006 Sep; 119(6):1440-6. PubMed ID: 16615116
[TBL] [Abstract][Full Text] [Related]
30. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas.
van den Donk M; van Engeland M; Pellis L; Witteman BJ; Kok FJ; Keijer J; Kampman E
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):327-33. PubMed ID: 17301267
[TBL] [Abstract][Full Text] [Related]
31. Unmetabolized Folic Acid in Prediagnostic Plasma and the Risk of Colorectal Cancer.
Cho E; Zhang X; Townsend MK; Selhub J; Paul L; Rosner B; Fuchs CS; Willett WC; Giovannucci EL
J Natl Cancer Inst; 2015 Dec; 107(12):djv260. PubMed ID: 26376686
[TBL] [Abstract][Full Text] [Related]
32. Alcohol consumption, genetic variants in the alcohol- and folate metabolic pathways and colorectal cancer risk: the JPHC Study.
Svensson T; Yamaji T; Budhathoki S; Hidaka A; Iwasaki M; Sawada N; Inoue M; Sasazuki S; Shimazu T; Tsugane S
Sci Rep; 2016 Nov; 6():36607. PubMed ID: 27827401
[TBL] [Abstract][Full Text] [Related]
33. Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer.
Webb PM; Ibiebele TI; Hughes MC; Beesley J; van der Pols JC; Chen X; Nagle CM; Bain CJ; Chenevix-Trench G; ;
Eur J Clin Nutr; 2011 Oct; 65(10):1133-40. PubMed ID: 21629268
[TBL] [Abstract][Full Text] [Related]
34. B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort.
Zschäbitz S; Cheng TY; Neuhouser ML; Zheng Y; Ray RM; Miller JW; Song X; Maneval DR; Beresford SA; Lane D; Shikany JM; Ulrich CM
Am J Clin Nutr; 2013 Feb; 97(2):332-43. PubMed ID: 23255571
[TBL] [Abstract][Full Text] [Related]
35. Gene-Nutrient Interaction between Folate and Dihydrofolate Reductase in Risk for Adenomatous Polyp Occurrence: A Preliminary Report.
Choi JH; Yates Z; Martin C; Boyd L; Ng X; Skinner V; Wai R; Veysey M; Lucock M
J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):455-9. PubMed ID: 26875486
[TBL] [Abstract][Full Text] [Related]
36. Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.
Neuhouser ML; Cheng TY; Beresford SA; Brown E; Song X; Miller JW; Zheng Y; Thomson CA; Shikany JM; Vitolins MZ; Rohan T; Green R; Ulrich CM
Int J Cancer; 2015 Aug; 137(4):930-9. PubMed ID: 25643945
[TBL] [Abstract][Full Text] [Related]
37. Genome-Wide Interaction Study of Dietary Intake and Colorectal Cancer Risk in the UK Biobank.
Hoang T; Cho S; Choi JY; Kang D; Shin A
JAMA Netw Open; 2024 Feb; 7(2):e240465. PubMed ID: 38411962
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation, dietary folate intake and risk of preterm birth in China.
Liu X; Lv L; Zhang H; Zhao N; Qiu J; He X; Zhou M; Xu X; Cui H; Liu S; Lerro C; Lin X; Zhang C; Zhang H; Xu R; Zhu D; Dang Y; Han X; Bai H; Chen Y; Tang Z; Lin R; Yao T; Su J; Wang W; Wang Y; Ma B; Huang H; Liang J; Qiu W; Liu Q; Zhang Y
Eur J Nutr; 2016 Jun; 55(4):1411-22. PubMed ID: 26138063
[TBL] [Abstract][Full Text] [Related]
39. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.
Wang X; Dai JY; Albanes D; Arndt V; Berndt SI; Bézieau S; Brenner H; Buchanan DD; Butterbach K; Caan B; Casey G; Campbell PT; Chan AT; Chen Z; Chang-Claude J; Cotterchio M; Easton DF; Giles GG; Giovannucci E; Grady WM; Hoffmeister M; Hopper JL; Hsu L; Jenkins MA; Joshi AD; Lampe JW; Larsson SC; Lejbkowicz F; Li L; Lindblom A; Le Marchand L; Martin V; Milne RL; Moreno V; Newcomb PA; Offitt K; Ogino S; Pharoah PDP; Pinchev M; Potter JD; Rennert HS; Rennert G; Saliba W; Schafmayer C; Schoen RE; Schrotz-King P; Slattery ML; Song M; Stegmaier C; Weinstein SJ; Wolk A; Woods MO; Wu AH; Gruber SB; Peters U; White E
Int J Epidemiol; 2019 Jun; 48(3):767-780. PubMed ID: 30476131
[TBL] [Abstract][Full Text] [Related]
40. Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; van Engeland M; Weijenberg MP
Cancer Causes Control; 2011 Jan; 22(1):1-12. PubMed ID: 20960050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
